Tongji Hospital: clinical-trial pipeline
Tongji Hospital is the sponsor of 384 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 182 are not yet finished and 13 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials182
Phase 2/3 and 314
Countries1
New in 90 days13
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 261 |
| Phase 4 | 37 |
| Phase 2 | 36 |
| Early phase 1 | 19 |
| Phase 1 | 10 |
| Phase 3 | 10 |
| Phase 1/2 | 7 |
| Phase 2/3 | 4 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 124 |
| Recruiting | 102 |
| Completed | 75 |
| Not yet recruiting | 71 |
| Active, not recruiting | 9 |
| Suspended or halted | 1 |
| Terminated | 1 |
| Withdrawn or not authorised | 1 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 136 |
| Gastroenterology and liver | 77 |
| Cardiovascular | 49 |
| Women's health and obstetrics | 43 |
| Infectious disease and vaccines | 36 |
| Nephrology and urology | 30 |
| Immunology and rheumatology | 28 |
| Neurology | 22 |
| Rare and genetic diseases | 17 |
| Metabolic and endocrine (diabetes, obesity) | 14 |
| Respiratory | 14 |
| Musculoskeletal | 7 |
Countries
| Country | Trials |
|---|---|
| China | 316 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-23 | New trial posted | Exploratory Study of the Efficacy of HAL-PDT in CIN 3 |
| 2026-10-21 | New trial posted | RWS of PDT for CIN 2 |
| 2026-10-14 | New trial posted | Treatment of Tension-type Headache by Zhixuan Analgesic Tablets |
| 2026-10-08 | New trial posted | Response-Guided Bladder Preservation With Trastuzumab Rezetecan, Adebrelimab, and Concurr… |
| 2026-10-05 | New trial posted | Temporal Interference Stimulation for Motor and Non-motor Symptoms in Parkinson's Disease |
| 2026-09-25 | New trial posted | Cardiorespiratory Fitness After Lobectomy Versus Sublobar Resection |
| 2026-09-24 | New trial posted | Multimodalomics-based Construction of Spatiotemporal Characteristics of Dynamic Liver Can… |
| 2026-09-23 | New trial posted | Adjuvant EGFR-TKI Therapy After Surgery for EGFR-Mutant High-Risk Stage IA2-IIB NSCLC |
| 2026-09-18 | New trial posted | MRI-Guided Temporal Interference Stimulation for Parkinson's Disease |
| 2026-09-16 | New trial posted | Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic Nephropathy |
| 2026-09-11 | New trial posted | The Relationship Between Novel Virological Indicators and Treatment With Different Nucleo… |
| 2026-09-04 | New trial posted | Efficacy of Mazdutide on Fatty Pancreas |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT07279597 | A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Mus… | Phase 2 | Not yet recruiting | |
| NCT06474520 | Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinI… | Not applicable | Recruiting | China |
| NCT07385755 | Desvenlafaxine for Preventive Treatment of Frequent Migraines | Not applicable | Active, not recruiting | China |
| NCT06917105 | Exploratory Clinical Study on the Safety and Efficacy of CAR-T Cell Therapy in the Treatment of Relapsed/Refr… | Phase 1/2 | Not yet recruiting | China |
| NCT07732504 | AI-Guided Surveillance and Curative Salvage of Recurrence After Hepatocellular Carcinoma Resection or Ablation | Not applicable | Not yet recruiting | China |
| NCT06467773 | TSPO-PET/MRI in Surveillance of Neuroinflammation in the Central Nervous System | Not applicable | Recruiting | China |
| NCT07528287 | Study on Biomarkers of Radiation-Induced Intestinal Injury | Not applicable | Not yet recruiting | |
| NCT07350837 | CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants | Early phase 1 | Recruiting | China |
| NCT07587216 | Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment | Not applicable | Recruiting | China |
| NCT07526493 | Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Ant… | Phase 1 | Recruiting | China |
| NCT07359235 | Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC) | Phase 1 | Recruiting | China |
| NCT07088354 | Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following N… | Not applicable | Recruiting | China |
| NCT06797024 | JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders | Not applicable | Recruiting | China |
| NCT07751146 | Nerve Block and Perioperative Myocardial Injury in Elderly Hip Fracture | Not applicable | Not yet recruiting | |
| NCT06885957 | Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD | Not applicable | Recruiting | China |
| NCT07409311 | Osellidine is Used for Analgesia During Daytime Hysteroscopic Surgery | Not applicable | Not yet recruiting | |
| NCT07259252 | Influenza Vaccination After Acute Coronary Syndrome | Not applicable | Recruiting | China |
| NCT07865611 | Response-Guided Bladder Preservation With Trastuzumab Rezetecan, Adebrelimab, and Concurrent Bladder Radiothe… | Phase 2 | Not yet recruiting | China |
| NCT07392567 | Prospective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer | Not applicable | Recruiting | China |
| NCT06890702 | Clinical Evaluation of New Biomarkers for Ischemic Cerebrovascular Disease | Not applicable | Recruiting | China |
| NCT07827456 | MRI-Guided Temporal Interference Stimulation for Parkinson's Disease | Not applicable | Not yet recruiting | |
| NCT06546904 | Artificial Intelligence Empowered Anesthesia Ultrasound Guided Regional Anesthesia Training | Not applicable | Not yet recruiting | China |
| NCT07413354 | Tislelizumab Combined With Huaier Granule as First-line Treatment for Unresectable Hepatocellular Carcinoma | Phase 2 | Recruiting | China |
| NCT07028593 | Effects of Ciprofol on Myocardial Injury After Non-cardiac Surgery in Video-Assisted Thoracoscopic Surgery | Phase 4 | Recruiting | China |
| NCT07729618 | AI-Guided First-Line Immunotherapy Selection in Unresectable Hepatocellular Carcinoma | Not applicable | Not yet recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Tongji Hospital clinical trials: 182 open, 14 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/tongji-hospital/, data as of 2026-10-25.